QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=61D0838D45F2925C0D585C1866D267A3;jsessionid=D629344B599B25C28D20DC1FF5A40034;jsessionid=1B1A77B04E6B3E0686D474E069EE0B27;jsessionid=CD8F5E6457A820DB260920D951684A3C;jsessionid=73DA4FFA85BC82C0652AAFCB6E26964A (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=61D0838D45F2925C0D585C1866D267A3;jsessionid=D629344B599B25C28D20DC1FF5A40034;jsessionid=1B1A77B04E6B3E0686D474E069EE0B27;jsessionid=CD8F5E6457A820DB260920D951684A3C;jsessionid=73DA4FFA85BC82C0652AAFCB6E26964A